We aim to make cervical screening more acceptable and accessible to women.
Program ROSE uses a revolutionary approach to cervical screening by:
Featuring self-sampling by women themselves, instead of pelvic examination by healthcare professionals.
HPV testing, instead of a pap smear diagnostic test for abnormal cells.
Use of secure digital e-health platform that allows women to have all their follow up communicated through their mobile phone.
Program ROSE was specifically designed for Malaysian women.
This evidence based approach can save lives and spare women and families from the suffering and financial hardship associated with cervical cancer.
ROSE AT A GLANCE
ROSE FOUNDATION was established in 2019 as a company limited by guarantee and as a charitable foundation in Malaysia. It is a joint venture between the University of Malaya and the Australian Centre for the Prevention of Cervical Cancer (formerly known as VCS, Victorian Cytology Service Inc.). ROSE Foundation also runs the ROSE Laboratory to provide a centralized cervical screening service using HPV testing.
ROSE Foundation has set itself the ambitious goal of making Malaysia one of the first nations in the region to be free of cervical cancer. To achieve this, the Foundation’s Program ROSE (Removing Obstacles to cervical ScrEening) was launched on 14 January 2019 by the Deputy Prime Minister and Minister of Women, Family and Community Development, Dato’ Seri Dr Wan Azizah Wan Ismail. Both the Ministry of Women, Family and Community Development and the Ministry of Health are also moving towards eliminating cervical cancer in Malaysia, and Program ROSE is playing a pivotal role in accelerating the process.
Program ROSE started off as Pilot Project ROSE, a research project led by University of Malaya. The aim of this pilot project was to assess the acceptability, feasibility and reach of a novel cervical screening strategy that utilized self-sampling in primary care settings, HPV (Human Papillomavirus) testing and follow-up of screened positive women in a tertiary hospital in Malaysia.
Instead of the conventional pap smear conducted by a healthcare professional, involving a pelvic examination, Program ROSE offers women the choice of using a self-swab: a quick, convenient and effective approach to enable molecular tests to be undertaken followed by prompt delivery of results straight to women's mobile phone.
1st Anniversary of the Launch of the Global Strategy for the Elimination of Cervical Cancer - 17 November 2021
On the 17th of November 2021, along with 194 other countries, Malaysia celebrated the
WHO cervical cancer elimination Day of Action.
ROSE Foundation is proud to be at the forefront of the Malaysian movement, together with all our partners, collaborators, volunteers, advocates & supporters, ROSE trustees & team members, towards a cervical cancer free Malaysia.
In conjunction with this historic worldwide movement, Program ROSE highlights stories of how Malaysians from all walks of life have joined in the efforts to make cervical cancer a rare disease.
ROSE Foundation celebrated her second birthday in July 2021 and while she's a young foundation, ROSE Foundation has come a long way. As we reflect on our journey, ROSE Foundation would like to THANK everyone that has and is continuing to believe in our cause - our donors & trustees, team members, volunteers, collaborators, communities and supporters who contributed towards Program ROSE.
ROSE Foundation is fully committed to our Vision and Mission* and we hope to walk and work alongside all Malaysians as we weather through these challenging times together.
Together, we can eliminate cervical cancer in Malaysia!
A Cervical Cancer Free Future for Women in Malaysia
To deliver cervical screening to women in Malaysia using Program R.O.S.E. (Removing Obstacles to cervical ScrEening) approach, aligned with the World Health Organization (WHO) cervical cancer elimination goals, prioritizing the under-screened population.
We are truly proud to congratulate and celebrate the achievements of our very own Professor Dr Woo Yin Ling for being awarded the prestigious 2021 FIGO Awards in Recognition of Female Obstetricians/Gynaecologists!
The FIGO Award (from the International Federation of Gynecology & Obstetrics) honours women - predominantly from low and middle-income countries - who have made a special contribution internationally or nationally to promote the development of science and scientific research in the fields of gynaecology and obstetrics. The Award also recognises women who throughout their careers have promoted better health for women, mothers and their children.
Professor Woo Ying Ling was also featured on the cover of Options, The Edge, November 8 edition. Find out more about her advocacy in the cover story here.
We are proud and grateful to be a recipient of TogetHER’s Cervical Cancer Grants Program 2021-2022. We aim to use this grant to engage with community leaders and stakeholders in promoting self-care and cultivate a network of trust and collaboration to encourage more women to participate in cervical screening.